Видео ютуба по тегу Fdasia

FDASIA Briefing
FDASIA Briefing
Introduction: About GDUFA
Introduction: About GDUFA
Managing Drug Shortages
Managing Drug Shortages
GDUFA
GDUFA
Reviewing FDA's Implementation of FDASIA
Reviewing FDA's Implementation of FDASIA
“The Use of SEND at the US Food and Drug Administration” by Dr. Stephanie Leuenroth-Quinn
“The Use of SEND at the US Food and Drug Administration” by Dr. Stephanie Leuenroth-Quinn
The Importance of Electronic Submissions for FDA Applications & FDASIA
The Importance of Electronic Submissions for FDA Applications & FDASIA
Kefauver Harris Celebration
Kefauver Harris Celebration
Gayatri Rao of FDA on FDASIA provisions and implementation at World Orphan Drug Congress USA 2013
Gayatri Rao of FDA on FDASIA provisions and implementation at World Orphan Drug Congress USA 2013
FDA Center of Excellence and the Drug Approval Process
FDA Center of Excellence and the Drug Approval Process
Direct Trust at FDASIA Health IT Public Workshop
Direct Trust at FDASIA Health IT Public Workshop
Demystifying the FDA (Stone)
Demystifying the FDA (Stone)
Rep. Pitts Statement on FDA Safety and Innovation Act
Rep. Pitts Statement on FDA Safety and Innovation Act
Examining FDA’s Medical Device User Fee Program
Examining FDA’s Medical Device User Fee Program
Breakthrough Therapy (December 2015)
Breakthrough Therapy (December 2015)
FDA Commissioner Scott Gottlieb, M.D. to Outline Agency Plans on Antibiotic Resistance
FDA Commissioner Scott Gottlieb, M.D. to Outline Agency Plans on Antibiotic Resistance
Generic Drugs Forum 2022 – Day 1, Session 2
Generic Drugs Forum 2022 – Day 1, Session 2
Introduction to FDA’s Office of Trade and Global Partnerships
Introduction to FDA’s Office of Trade and Global Partnerships
PDUFA V, the FDA, and the Need for Flexibity
PDUFA V, the FDA, and the Need for Flexibity
Unwrapping FDA's 2012 UFA Package: What's in the Statute?
Unwrapping FDA's 2012 UFA Package: What's in the Statute?
Rep. Upton Statement on FDA Safety and Innovation Act
Rep. Upton Statement on FDA Safety and Innovation Act
Quality-Related Compliance Actions and Trends (15of33) Quality – Oct. 16-17, 2019
Quality-Related Compliance Actions and Trends (15of33) Quality – Oct. 16-17, 2019
Securing the U.S. Drug Supply Chain: Oversight of FDA’s Foreign Inspection Program
Securing the U.S. Drug Supply Chain: Oversight of FDA’s Foreign Inspection Program
Orange Book Exclusivity: Part II - Pediatric, Orphan, and GAIN
Orange Book Exclusivity: Part II - Pediatric, Orphan, and GAIN
Hearing on
Hearing on "Reviewing FDA's Implementation of FDASIA"